Cargando…
Nitric Oxide as a Potential Adjuvant Therapeutic for Neuroblastoma: Effects of NO on Murine N2a Cells
Neuroblastoma, the most common extracranial solid tumor in children, accounts for 15% of all pediatric cancer deaths. Pharmaceutical applications of S-Nitrosylation, which, under normal conditions is involved with a host of epigenetic and embryological development pathways, have exhibited great pote...
Autores principales: | Gordon, Jenna L., Reynolds, Melissa M., Brown, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355501/ https://www.ncbi.nlm.nih.gov/pubmed/32340209 http://dx.doi.org/10.3390/vetsci7020051 |
Ejemplares similares
-
Anticancer potential of nitric oxide (NO) in neuroblastoma treatment
por: Gordon, Jenna L., et al.
Publicado: (2021) -
Anticancer Impact of Nitric Oxide (NO) and NO Combination with SMYD-3 Inhibitor on Breast Carcinomas
por: Gordon, Jenna L., et al.
Publicado: (2021) -
Nitric oxide-releasing emulsion with hyaluronic acid and vitamin E
por: Yapor, Janet P., et al.
Publicado: (2019) -
Nitric oxide as a surgical adjuvant
por: Krausz, Aimee, et al.
Publicado: (2015) -
Cell-Based Methods for Determination of Efficacy for Candidate Therapeutics in the Clinical Management of Cancer
por: Gordon, Jenna L., et al.
Publicado: (2018)